Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.
2016 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains is VPGMarketResearchs new study of the major business opportunities emerging in the European cancer diagnostics market during the nextfive years. The report examines trends in the European market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
France, Germany, Italy, Spain, UK
European Market Overview
- Five-year test volume and sales projections by country.
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
- Estimated universe of laboratories performing cancer diagnostic testing
- Cancer statistics, etiology and recent developments in Europe.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Immunohistochemical Stains
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major cancer diagnostic product
suppliers by individual test and country.
- Five-year test volume and sales forecasts
for major tumor markers by country and market segment, including:
Physician Offices/Group Practices
- Analysis of major molecular diagnostic and immunodiagnostic analyzers
used for cancer testing, including their operating characteristics,
features and selling prices.
- Assessment of latest technologies
and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.
- Strategic assessments ofmajor suppliers
and start-up firms developing innovative cancer diagnostic
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.
- The companies analyzed in the report include:
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- Correlogic Systems/Vermillion
- Decode Genetics
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Guided Therapeutics
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Quest Diagnostics
- Radient Pharmaceuticals
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Wako Pure Chemicals
Contains 820 pages and 320 tables
SIMILAR MARKET STUDIES
This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by ...
January 2014 | $3150 | View Details >>
Summary This comprehensive report from VPGMarketResearch.com contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features ...
January 2017 | $0 | View Details >>
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Future Horizons and Growth Strategies in the Global Septicemia Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
2016-2020 Survey of the Blood Typing, Grouping and Infectious Disease Screening Market in 33 Countries-Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
This comprehensive 39-country report from VPGMarketResearch.com contains 1,025 pages, 387 tables and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five ...
May 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research